Merrimack Pharma (MACK) said to review strategic alternatives - Reuters

November 9, 2016 10:01 AM EST
Get Alerts MACK Hot Sheet
Trade MACK Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Merrimack Pharma (NASDAQ: MACK) said to review strategic alternatives - Reuters.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Mergers and Acquisitions, Rumors, Trader Talk

Add Your Comment